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BIOPHYSICS

Electro-mechanical coupling of KCNQ channels is
a target of epilepsy-associated mutations
and retigabine
Nien-Du Yang1†, Richard Kanyo2†, Lu Zhao1, Jingru Li2, Po Wei Kang1, Alex Kelly Dou1,
Kelli McFarland White1, Jingyi Shi1, Jeanne M. Nerbonne3, Harley T. Kurata2*, Jianmin Cui1*
KCNQ2 and KCNQ3 form the M-channels that are important in regulating neuronal excitability. Inherited mutations
that alter voltage-dependent gating of M-channels are associated with neonatal epilepsy. In the homolog KCNQ1
channel, two steps of voltage sensor activation lead to two functionally distinct open states, the intermediate-open
(IO) and activated-open (AO), which define the gating, physiological, and pharmacological properties of KCNQ1.
However, whether the M-channel shares the same mechanism is unclear. Here, we show that KCNQ2 and KCNQ3
feature only a single conductive AO state but with a conserved mechanism for the electro-mechanical (E-M)
coupling between voltage sensor activation and pore opening. We identified some epilepsy-linked mutations in
KCNQ2 and KCNQ3 that disrupt E-M coupling. The antiepileptic drug retigabine rescued KCNQ3 currents that
were abolished by a mutation disrupting E-M coupling, suggesting that modulating the E-M coupling in KCNQ
channels presents a potential strategy for antiepileptic therapy.

The KCNQ voltage-gated potassium (Kv) channel family (KCNQ1
to KCNQ5) serves diverse physiological functions, from regulating
cardiac action potential duration (1, 2), maintaining epithelial salt
homeostasis (3), to modulating neuronal excitability (4–6). Like
other Kv channels, KCNQ channels adopt a canonical topology as
tetramers, with each  subunit containing six transmembrane segments S1 to S6. S1 to S4 of each  subunit form the voltage-sensing
domain (VSD) that senses changes in membrane potential, while S5
and S6 from all four  subunits comprise the central K+-selective
pore (7, 8). Voltage-dependent gating of Kv channels involves three
fundamental molecular processes: VSD activation, VSD-pore coupling, and pore opening. In response to membrane depolarization,
the positively charged S4 segment moves toward the extracellular
space and changes the conformation of the VSD, a process known
as “VSD activation.” The conformational changes in the VSD then
trigger a series of interactions between the VSD and the pore, a process known as “VSD-pore coupling” or “electro-mechanical (E-M)
coupling,” to open the channel and conduct ionic current.
The VSDs of KCNQ1 activate in two steps upon membrane
depolarization: first from the resting state to an experimentally
resolvable intermediate state and then proceed to the fully activated
state (9–15). Previous work showed that the KCNQ1 channel opens
when its VSDs occupy both the intermediate and fully activated
conformations, resulting in two conductive states, the intermediate-
open (IO) and activated-open (AO) states (12–18). The IO and AO
states have different properties including channel modulation (12),
pharmacology (12, 14, 17, 19), and regulation by cell signaling
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(20–22). Distinctive regulation of the IO and AO states by various
KCNE auxiliary subunits causes the channel complex to adopt
different balances of IO- and AO-associated properties, underlying
tissue-specific KCNQ1 current phenotypes (12, 14).
Our previous studies demonstrated that stepwise VSD activation
of KCNQ1 induces pore opening at the IO and AO states via distinctive sets of E-M coupling interactions (15). When S4 moves to
the intermediate state, the S4-S5 linker interacts with the bottom
of the S6 in the same subunit, which is essential for the channel to
open to both the IO and AO states. When S4 then transitions to the
fully activated state, the S4 and S4-S5 linker of one subunit interact
with S5 and S6 of the neighboring subunit. These interactions are
important specifically for triggering the pore to open to the AO
state. The specific mechanisms of E-M coupling for the two open
states provide the basis for some of the IO- and AO-specific properties. For instance, ML277, a KCNQ1 activator, was found to only
enhance the AO state occupancy by perturbing the E-M coupling
specific for the AO state (17). In addition, some disease-associated
mutations in KCNQ1 could specifically disable the E-M coupling of
individual KCNQ1 open states (12, 15, 16, 23).
KCNQ2 and KCNQ3 form the heterotetrameric M-channels
(KCNQ2/3) that primarily mediate the M-current in neurons (4, 24).
KCNQ4 and KCNQ5 also contribute to M-currents (5, 6). The M-current
activates at subthreshold potentials to regulate action potential firing of neurons (25, 26). Reflecting its key role in controlling neuronal excitability, congenital mutations in KCNQ2 and KCNQ3 that
alter M-current function are commonly associated with forms of
early-onset epilepsy (27), including benign familial neonatal convulsions (BFNC) (28–31) and the more severe early infantile epileptic
encephalopathy (EIEE) (32–34). Activation of M-current hyperpolarizes neurons and suppresses membrane excitability, making
the neuronal KCNQ channels prime therapeutic targets against
epilepsy. As a result, numerous synthetic compounds specifically
targeting neuronal KCNQ channels have been developed (35, 36),
such as ztz240 (37), ICA069673 (38), retigabine (RTG) (37, 39), and
ML213 (40, 41). On the other hand, naturally occurring compounds
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RESULTS

KCNQ2 and KCNQ3 only conduct with fully activated
VSD conformation
KCNQ1 to KCNQ3 show high conservation of the VSD including
residues critical for voltage-dependent activation (fig. S1A) and are
predicted from the sequence alignment to have similar VSD structures. A recent cryo–electron microscopy (cryo-EM) structure of
human KCNQ2 (37) displays similar S2-S4 registrations within the
VSD as the previously published human KCNQ1 cryo-EM structure (8), with the charge transfer center residues E2 (E140) (E170 in
KCNQ1) and F0 (F137) (F167 in KCNQ1) on S2 and D172 (D202 in
KCNQ1) on S3 interacting with gating charge R5 (R210) (H5,
H240 in KCNQ1) on S4, indicating conservation of the fully activated
VSD conformation (Fig. 1A). The KCNQ3 VSD structure, although
not available, is expected to be similar based on sequence homology.
Previous structure-function studies have shown that the KCNQ1
VSD sequentially occupies two functionally stable and detectable
states during voltage-dependent activation: from the resting to the
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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intermediate and then to the fully activated state (Fig. 1B) (9–15).
KCNQ1 can open when its VSDs adopt either the intermediate or
fully activated states, resulting in two open states, the IO and the
AO (Fig. 1C) (12–18). The two open states of KCNQ1 display distinct properties in their activation, pharmacological modulation,
and tissue-specific auxiliary subunit regulation (12–18). However,
whether KCNQ2 and KCNQ3 also feature a two-step VSD activation and two open states similar to KCNQ1 is unknown. Throughout
our study, we used the expression-optimized KCNQ3A315T mutant
(46) for homomeric expression of KCNQ3 channels (see Materials
and Methods). To track VSD transitions, we used the voltage clamp
fluorometry (VCF) technique in KCNQ3, in which the S3-S4 linker
of the channel is labeled by a fluorophore, to allow monitoring of
VSD movement and pore opening simultaneously during voltage-
dependent activation. We developed the KCNQ3 VCF construct
KCNQ3A315T/Q218C/L156W/L157F (denoted as KCNQ3*) using aromatic
substitutions guided by sequence differences with KCNQ1 that
generates larger fluorescence signals compared to previous reports
(Fig. 1D and fig. S1, B and C) (45) and has minimal effects on channel gating (fig. S1D). We found that KCNQ3* fluorescence-voltage
(F-V) relation is well fit by a single Boltzmann function and closely
overlaps with its conductance-voltage (G-V) relation (Fig. 1E). This
is consistent with previous KCNQ3 VCF studies (45, 47), although
we note that VCF signals from KCNQ3 remain challenging to
record, likely underlying slight differences between studies, and
challenges with understanding the exact relationship between activation of the VSD and pore opening. In addition, KCNQ3* shows
double-exponential current and fluorescence activation kinetics
with a small contribution of a slow component (Fig. 1D). A recent
VCF study of KCNQ2 showed a similar result (48). These results
differ from the VCF recordings of KCNQ1, which exhibit two
well-separated components in the F-V relation (F1 and F2) as the
result of the two-step VSD activation (Fig. 1E) (12–18). Thus, these
results suggest that KCNQ2 and KCNQ3 may differ from KCNQ1
by lacking a stable intermediate state of the VSD or two open states.
While the intermediate and fully activated VSD conformations
have been experimentally determined in KCNQ channels, the resting VSD state remains poorly understood. Despite some functional
and modeling studies, the precise conformation of the resting VSD
state in KCNQ channels is unclear as it has not been structurally
defined. Nevertheless, this did not affect our measurements of VSD
movements to the intermediate and fully activated states.
To test whether KCNQ2 and KCNQ3 have only one open state and
whether the single open state represents the AO state, we applied
a double charge-reversal mutagenesis strategy (9, 12, 14, 49, 50) to
arrest KCNQ2 and KCNQ3 VSDs in the fully activated VSD conformation and probed the pore opening of the channels. We generated a
series of KCNQ2 and KCNQ3 charge-switching mutants designed
to promote electrostatic interactions between specific residue pairs
found in the activated VSD structure of KCNQ2 (Fig. 1, A and B)
(37): F0R (Q2-F137R, Q3-F167R) paired with R5E (Q2-R210E,
Q3-R239E) and D172N (Q2-D172N, Q3-D202N) (Fig. 1, G and J).
These engineered activated VSD–stabilizing (AO-locked) KCNQ2
and KCNQ3 mutants generated constitutively open channels with
minimal voltage dependence (Fig. 1, G and J, and fig. S2, B and D) compared to wild-type KCNQ2 and KCNQ3A315T channels (Fig. 1, F and I,
and fig. S2, A and C). This is consistent with the idea that these mutations strongly stabilize the fully activated VSD state for conduction
at the constitutive AO state. To also probe whether KCNQ2 and
2 of 14
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such as polyunsaturated fatty acids (42) and endocannabinoids (43)
have been recently found as potent KCNQ activators. Among all the
compounds, RTG is a first-in-class antiepileptic drug approved for
human use as an adjunctive treatment for refractory epilepsy (44).
A recent study showed that RTG stabilizes both the open conformation of the pore and the activated conformation of the VSD, suggesting an activation mechanism via E-M coupling (45). Recent
RTG-bound KCNQ structures also revealed that RTG binds at a
pocket between adjacent pore segments of the channel and interacts
with residues important for E-M coupling (37, 39). These findings
make RTG a suitable candidate drug to study the E-M coupling in
neuronal KCNQ channels.
KCNQ2 to KCNQ5 share sequence and structure homology
as well as many important mechanisms of function with KCNQ1
(7, 8, 37, 39, 41). However, whether the neuronal KCNQ channels
also feature two open states in voltage-dependent gating remains
elusive, which hinders further understanding of the molecular
mechanism for E-M coupling. Furthermore, the link between E-M
coupling in neuronal KCNQ channels and human pathophysiology
has not been established. Despite extensive studies, whether
antiepileptic compounds such as RTG modulates KCNQ channels
by altering the E-M coupling has not been fully explored. A deeper
understanding of the open state and E-M coupling mechanisms in
different KCNQ channels will provide fresh insights into how these
channels function and how inherited mutations affecting KCNQ
function lead to disease.
In this study, we combined site-directed mutagenesis, electrophysiology, fluorescence measurements, and pharmacology to elucidate the E-M coupling mechanism in neuronal KCNQ2 and KCNQ3
channels. On the basis of the sequence and structure homology be
tween KCNQ1, KCNQ2, and KCNQ3, we designed a set of functional
experiments and revealed key similarities and differences in their E-M
coupling during voltage-dependent gating. We then took advantage
of the antiepileptic prototype drug RTG to demonstrate the impact of
modulating E-M coupling in loss-of-function KCNQ2 and KCNQ3
mutants. Our approach and results extend the established framework
for KCNQ1 gating mechanism, and build a foundation for understanding
the physiological significance, disease pathogenesis, and pharmacological
modulation of E-M coupling in neuronal KCNQ channels.
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KCNQ3 can conduct at the IO state, we generated another class of
charge-switching mutants designed to promote electrostatic interactions between specific residue pairs found in the KCNQ1 intermediate VSD structure (14): F0R paired with Q3E (Q2-Q204E,
Q3-Q233E) and D172N (Fig. 1, H and K). These intermediate
VSD–stabilizing (IO-locked) KCNQ2 and KCNQ3 mutants yielded
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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negligible currents despite robust surface membrane expression as
detected by Western blot (Fig. 1, H and K, and fig. S3A), suggesting
that the mutant channels could not open. Additional pairs of
KCNQ3 IO-locked E2R/R4E (E170R/R236E) and AO-locked E2R/
R5E (E170R/R239E) mutants also produced nonfunctional and
constitutively open channels, respectively (fig. S2, E and F). Together,
3 of 14

Downloaded from https://www.science.org at Washington University on August 30, 2022

Fig. 1. KCNQ2 and KCNQ3 are only conductive when the VSDs occupy the fully activated conformation. (A) Overlay of the human KCNQ1 VSD [Protein Data Bank
(PDB): 6UZZ, gold] and KCNQ2 VSD (PDB: 7CR3, silver) cryo-EM structures. R1 to R6: positive gating charges on S4. E1 and E2: negative counter-charges on S2. F0: the
aromatic residue on S2. Structures are aligned to S2. S1 is not shown for clarity. (B) Cartoons illustrating the key S2-S4 interactions during a two-step KCNQ1 VSD activation.
Positive gating charges and polar residues are colored red and green, negative counter charges are colored blue, and F0 on S2 is colored yellow. (C) Table summarizing
the pore states of KCNQ1-KCNQ3 at the intermediate and fully activated VSD conformations. (D) Representative current (black) and fluorescence (green) traces for
KCNQ3A315T/Q218C/L156W/L157F (KCNQ3*). Blue lines are double-exponential fits to the activation kinetics. VCF was recorded at holding potential of −140 mV, followed by
1.5-s depolarizing pulses between −140 mV and +60 mV in 10-mV increments, before returning to −20 mV to measure tail currents. (E) G-V (black) and F-V (green) relations
of KCNQ3* and F-V relation of KCNQ1C214A/G219C/C331A (KCNQ1*) (blue). V1/2 and k for KCNQ3* G-V: −33.5 ± 1.3 mV and 12.2 ± 1.7 mV (n = 8), for KCNQ3* F-V: −27.6 ± 0.7 mV
and 20.3 ± 0.6 mV (n = 4), for KCNQ1* F1-V: −51.9 ± 2.7 mV and 14.3 ± 0.4 mV (n = 5), and for KCNQ1* F2-V: 43.8 ± 2.7 mV and 23.5 ± 1.7 mV (n = 5). (F and I) Representative
current traces for KCNQ2WT and KCNQ3A315T. (G, H, J, and K) Cartoon schematics and representative current traces of AO- and IO-locked mutants. Insets: Western blot
results for membrane expression of the mutants. All traces are shown with 20-mV increments for clarity.

SCIENCE ADVANCES | RESEARCH ARTICLE
these results suggest that KCNQ2 and KCNQ3 have one steadystate VSD activation from the resting to the fully activated state and
conduct only at the AO state. This contrasts with KCNQ1, which
features both conductive IO and AO states associated with a twostep VSD activation (Fig. 1C).

Fig. 2. Residues specific for the AO state E-M coupling are conserved in KCNQ1 to KCNQ3 channels. (A) Sequence alignment of KCNQ1 to KCNQ3 S4-S5 linker and
S6. Residues important for the KCNQ1 AO state E-M coupling are colored red and blue. Conserved AO state E-M coupling residues in KCNQ2 and KCNQ3 are bolded.
(B) Conserved AO state E-M coupling residues W218 (red) and S303 (blue) in the human KCNQ2 cryo-EM structure (PDB: 7CR3). S5 and S6 from a neighboring subunit are
shown in gold. (C to E) Representative current traces for KCNQ2WT, KCNQ2W218R, and KCNQ2S303F. (F to H) Representative current traces for KCNQ3A315T, KCNQ3A315T/W247R,
and KCNQ3A315T/S342F. Insets: Western blot results for membrane expression of the mutants. (I) Top: Representative current (black) and fluorescence (green) traces for
KCNQ3*S342F (KCNQ3* denotes the VCF construct) recorded using the voltage protocol described in Fig. 1D legends. Bottom: F-V relation of KCNQ3*S342F (green filled
circle). V1/2 and k for KCNQ3*S342F: −3.3 ± 2.1 mV and 16.9 ± 1.7 mV (n = 6). Dashed line is the Boltzmann fit for KCNQ3* F-V reproduced from Fig. 1E.
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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Residues important for the AO state E-M coupling are
conserved in KCNQ channels
It has been shown that KCNQ1 VSD activation to the intermediate
and the fully activated states engages two distinct sets of E-M
coupling interactions to induce pore opening, resulting in the IO and
AO states (15). In particular, our previous studies have identified
the E-M coupling interactions specific for the KCNQ1 AO state,
which involve residues in the C terminus of S4, the N terminus of
the S4-S5 linker, and part of S5 and S6 (15). Sequence alignment
reveals that most of these residues are conserved in KCNQ2 and
KCNQ3 (Fig. 2A), suggesting the conservation of the E-M coupling
mechanism specifically for the AO state. In previous studies, we
found two disease-associated KCNQ1 mutations W248R and S338F
that selectively eliminate the AO state by disabling E-M coupling
when the VSDs occupy the fully activated state; however, these

mutants remain conductive at the IO state (15–17). These tryptophan and serine residues are conserved in KCNQ2 and KCNQ3 as
well (Fig. 2A), located in the N terminus of the S4-S5 linker and the
middle of S6, respectively (Fig. 2B). We therefore made the identical
mutations as in KCNQ1 to examine the effects on currents of
homomeric KCNQ2 and KCNQ3A315T channels. W218R and S303F
mutations in KCNQ2, and W247R and S342F mutations in KCNQ3A315T
abolished currents, despite robust expression of the channel proteins
in the membrane as detected by Western blot (Fig. 2, C to H, and
fig. S3B). In addition, KCNQ2S303F and KCNQ2W218R mutants exerted a dominant-negative effect by strongly suppressing homomeric
KCNQ2 currents when coexpressed with wild-type KCNQ2 (fig. S4, A
to D). We further carried out VCF experiments and observed robust
voltage-dependent fluorescence signals from the KCNQ3*S342F mutant
despite diminished current expression (Fig. 2I), demonstrating that
the S342F mutation specifically ablates pore opening without eliminating VSD activation. These results together showed that residues
specific for the AO state E-M coupling are conserved in KCNQ1 to
KCNQ3 channels, and suggest that, in KCNQ2 and KCNQ3, there is
no open state other than the AO state when the VSD reaches the fully
activated conformation.

SCIENCE ADVANCES | RESEARCH ARTICLE
KCNQ2 and KCNQ3 exhibit permeant ion regulation
and pharmacology homologous to the AO state of KCNQ1
Previous studies in KCNQ1 have shown that IO and AO states have
distinct pharmacological sensitivity and modulation by permeating
ions (12, 14, 17). For example, KCNQ1 channels predominantly
open to the IO state and exhibit a large Rb+/K+ inward tail current
ratio of ~3, whereas IKs channels (KCNQ1 + KCNE1) exclusively
open at the AO state and show a much smaller Rb+/K+ tail current
ratio of ~1, attributed to altered rapid gating transitions in the presence of Rb+ (12, 51). We compared the ion permeation of KCNQ2
and KCNQ2 + KCNQ3 with the KCNQ1 IO and AO states. By measuring the instantaneous tail current amplitudes of the channels
at −60 mV after a +60-mV prepulse for 5 s in 100 mM K+ or Rb+
solutions (Fig. 3, A and B), we found that both homomeric KCNQ2

and heteromeric KCNQ2 + KCNQ3 exhibited a small Rb+/K+ tail
current ratio (Fig. 3E), resembling the KCNQ1 AO state (Fig. 3D)
(12, 51). We also tested the ion permeation of a KCNQ2 AO-locked
mutant (Fig. 3C) and found that the Rb+/K+ tail current ratios
were not different from wild-type channels (Fig. 3E). These comparisons suggest that the AO state of KCNQ2 and KCNQ2 + KCNQ3
channels features permeant ion regulation resembling that of the
KCNQ1 AO state.
A recent study revealed that the compound C28 differentially
affects the IO and AO states in KCNQ1 (19). C28 was found to
promote KCNQ1 opening by two mechanisms. First, C28 induces a
hyperpolarizing shift in the voltage dependence of VSD activation.
Second, C28 selectively enhances the E-M coupling of the AO
state to increase IKs currents, but not the IO state so that it does not

Downloaded from https://www.science.org at Washington University on August 30, 2022
Fig. 3. KCNQ2 and KCNQ3 show permeant ion regulation and pharmacology homologous to the KCNQ1 AO state. Representative current traces for (A) KCNQ2WT,
(B) KCNQ2 + KCNQ3, and (C) KCNQ2F0R/R5E/D172N recorded in 96 mM Na+ (black), 100 mM K+ (blue), or 100 mM Rb+ (green) external solutions. The tail currents were elicited
at −60 mV for 3 s from a prepulse at +60 mV for 5 s. (D) Table summarizing the Rb+/K+ inward tail current ratios of the open states of KCNQ1, KCNQ2, and KCNQ2/3.
(E) Average Rb+/K+ inward tail current ratios calculated from the instantaneous tail current amplitudes for KCNQ2WT (0.55 ± 0.02, n = 8), KCNQ2 + KCNQ3 (0.46 ± 0.02,
n = 7), and KCNQ2F0R/R5E/D172N (0.55 ± 0.03, n = 7). Dots represent individual cells recorded. Statistical significance was determined by one-way analysis of variance (ANOVA)
followed by Tukey’s post hoc test. ns, not significant. *P < 0.05. (F) Representative current traces and (G) G-V relations of KCNQ2WT before and after 10 M C28. V1/2 for
control (black): −39.3 ± 2.2 mV (n = 5) and for 10 M C28 (blue): −57.7 ± 2.7 mV (n = 5). (H) Representative current traces and (I) G-V relations of KCNQ3A315T before and
after 10 M C28. V1/2 for control (black): −48.8 ± 1.1 mV (n = 5) and for 10 M C28 (blue): −94.5 ± 3.2 mV (n = 5).
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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increase KCNQ1 currents (19). Since KCNQ2 and KCNQ3 only
open to the AO state, we tested if C28 would act similarly to increase the
maximum conductance of homomeric KCNQ2 and KCNQ3A315T
channels. We found that C28 also activated KCNQ2 and KCNQ3A315T
(Fig. 3, F and H) by shifting the G-V relation to more negative voltages.
At 10 M C28, the G-V shift was ~−18 mV for KCNQ2 as compared
to ~−46 mV for KCNQ3A315T (Fig. 3, G and I). Similar to the results
in IKs channels (KCNQ1 AO state) (19), C28 increased the maximum conductance of KCNQ2 and KCNQ3A315T by more than 50%
(Fig. 3, G and I). Our results together demonstrate that KCNQ2 and
KCNQ3 show permeant ion sensitivity and pharmacology that
resemble the AO state properties described in KCNQ1.

Fig. 4. Mutational disruptions of the AO state E-M coupling in KCNQ2 or KCNQ3 subunits impair the heteromeric M-channel function. Representative current
traces for (A) KCNQ2WT, (B) KCNQ2 + KCNQ3, (C) KCNQ2S303F + KCNQ3WT, (D) KCNQ2W218R + KCNQ3WT, (E) KCNQ2WT + KCNQ3S342F, (F) KCNQ2WT + KCNQ3W247R, (G) KCNQ2S303F +
KCNQ3A315T, and (H) KCNQ2W218R + KCNQ3A315T. (I) Steady-state currents normalized to KCNQ2 + KCNQ3 (100 ± 10.1%, n = 6) were 64.3 ± 14.3% (n = 7) for KCNQ2WT + KCNQ3S342F
and 39.3 ± 14.7% (n = 7) for KCNQ2WT + KCNQ3W247R. (J) G-V relations of KCNQ2WT (black open circle), KCNQ2 + KCNQ3 (black open square), KCNQ2WT + KCNQ3S342F (gray
open triangle), and KCNQ2WT + KCNQ3W247R (gray open inverted triangle). V1/2 for KCNQ2WT: −41.5 ± 0.7 mV (n = 5), for KCNQ2 + KCNQ3: −43.2 ± 1.0 mV (n = 6), for
KCNQ2WT + KCNQ3S342F: −22.2 ± 1.4 mV (n = 7), and for KCNQ2WT + KCNQ3W247R: −29.4 ± 0.9 mV (n = 7). (K) Steady-state currents normalized to KCNQ3A315T (100 ± 11.9%,
n = 5) were 10.3 ± 24.6% (n = 5) for KCNQ2S303F + KCNQ3A315T and 19.5 ± 18.6% (n = 6) for KCNQ2W218R + KCNQ3A315T. (L) G-V relations of KCNQ3A315T (black open
circle), KCNQ2WT + KCNQ3A315T (black open square), KCNQ2S303F + KCNQ3A315T (gray open triangle), and KCNQ2W218R + KCNQ3A315T (gray open inverted triangle). V1/2
for KCNQ3A315T: −48.1 ± 0.6 mV (n = 5), for KCNQ2WT + KCNQ3A315T: −38.9 ± 1.0 mV (n = 5), for KCNQ2S303F + KCNQ3A315T: −26.3 ± 2.1 mV (n = 5), and for KCNQ2W218R +
KCNQ3A315T: −21.9 ± 1.6 mV (n = 6). Statistical significance was determined by Student’s t test. **P < 0.01.
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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Disruptions of the AO state E-M coupling in KCNQ2 or
KCNQ3 subunits result in loss-of-function phenotypes
in the heteromeric M-channel
KCNQ2 and KCNQ3 subunits are important contributors to native
“M-current” in neurons (4, 24). When expressed in Xenopus oocytes,
KCNQ2 coassembles with KCNQ3 to form heteromeric “M-channels”
that result in larger currents compared to KCNQ2 homomers alone
(Fig. 4, A and B) (4). We have previously shown in KCNQ1 channels that the AO state–specific E-M coupling involves interactions
between the S4 and S4-S5 linker from one subunit with the S5 and
S6 of a neighboring subunit (15). In a heteromeric M-channel, the
VSD of each KCNQ2 (or KCNQ3) subunit may make substantial

contacts with the pore of a neighboring KCNQ3 (or KCNQ2) subunit (37). Therefore, the AO state E-M coupling in M-channels is an
intersubunit interaction between KCNQ2 and KCNQ3 subunits. With
the tools that can selectively disable the AO state E-M coupling in
homomeric KCNQ2 or KCNQ3 channels (Fig. 2), we sought to dissect
the E-M coupling in heteromeric M-channels. We first examined the
impact of KCNQ2 by coexpressing wild-type KCNQ3 with KCNQ2
carrying the AO state–eliminating (AO-less) mutations. Notably, coexpression of the KCNQ2S303F or KCNQ2W218R mutant strongly suppressed M-current amplitude (Fig. 4, C and D). On the other hand,
coexpression of wild-type KCNQ2 with the KCNQ3 AO-less mutant
KCNQ3S342F or KCNQ3W247R led to weaker suppression of M-current
amplitude (Fig. 4, E, F, and I) but shifted the G-V relation to more
positive voltages compared to wild-type KCNQ2 + KCNQ3 (~+21 and
~+14 mV, respectively) or wild-type KCNQ2 (~+19 and ~+12 mV, re
spectively) (Fig. 4J). These results suggest that in heteromeric M-channels,
the KCNQ2 AO-less mutant subunits strongly abolished channel func
tion, whereas KCNQ3 AO-less mutants modified channel function by
reducing current amplitude and shifting the G-V relation.
However, the wild-type KCNQ3 and the KCNQ2 AO-less mutants,
when expressed alone, all show negligible currents (Fig. 2, D and E)
(46). Therefore, it was not clear if the KCNQ2 AO-less mutant subunits abolished M-currents (Fig. 4, C and D) by a dominant-negative
effect, or instead by failing to associate with wild-type KCNQ3 (which
gives rise to little or no current in the absence of KCNQ2 (46)). To
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answer this question, we coexpressed KCNQ2 AO-less mutants with
KCNQ3A315T to examine their effects on the currents of KCNQ3A315T. We
found that coexpression of the KCNQ2S303F or KCNQ2W218R mutant
suppressed the KCNQ3A315T currents (Fig. 4, G, H, and K) and
shifted the G-V relation to more positive voltages compared to
KCNQ3A315T (~+22 and ~+26 mV, respectively) or wild-type KCNQ2 +
KCNQ3A315T (~+13 and ~+17 mV, respectively) (Fig. 4L). The
altered voltage dependence (compared to homomeric channels) after
mutant subunit coexpression demonstrates that the AO-less mutants
of both KCNQ2 and KCNQ3 can coassemble with their counterpart,
leading to suppression of heteromeric M-channel function along
with altered gating properties. In summary, our findings suggest
that disruptions of the AO state E-M coupling by mutations in
KCNQ2 or KCNQ3 subunits affect the intersubunit E-M coupling
interactions in heteromeric channels to impair M-current function.
Epilepsy-linked mutations in KCNQ2 and KCNQ3 subunits
disrupt E-M coupling
Inherited mutations in KCNQ2 and KCNQ3 are frequently associated
with neonatal epilepsies (27–34). To explore whether the AO state

E-M coupling in KCNQ2 and KCNQ3 has direct implications for
human pathophysiology, we searched the National Center for
Biotechnology Information (NCBI) ClinVar database for conserved
AO state E-M coupling residues in KCNQ2 and KCNQ3 (Fig. 2A
and fig. S5A) identified in patients. Of the ten conserved coupling
residues in KCNQ2 (W218, L220, L221, V225, Y237, I238, L241,
S303, F304, and L307), we found three mutations [Y237C (52),
I238V, and F304S (53, 54)] that are associated with EIEE and one
mutation (I238L) that is likely pathogenic (fig. S5A). On the other
hand, of the nine conserved coupling residues in KCNQ3 (W247,
L249, L250, Y266, I267, L270, S342, F343, and L346), we only found
one mutation (Y266C) (homologous to Y237C in KCNQ2) (55)
that is likely pathogenic (fig. S5A). These mutations on S5 and S6 of
the channel are in close proximity to each other and to the AO-less
mutations (fig. S5B). The KCNQ2F304S mutant, when expressed
alone (Fig. 5A) or coexpressed with wild-type KCNQ3 (Fig. 5B),
suppressed current amplitude (Fig. 5C) and shifted the G-V relation to
more positive voltages (shifted ~+31 mV for KCNQ2F304S + KCNQ3WT)
compared to the wild-type controls (Fig. 5D). On the other hand,
the KCNQ2Y237C mutant with or without the coexpression of
Downloaded from https://www.science.org at Washington University on August 30, 2022

Fig. 5. KCNQ2 and KCNQ3 mutations associated with EIEE disrupt the E-M coupling. (A and B) Representative current traces for KCNQ2F304S with and without
coexpressed KCNQ3WT. (C) Steady-state currents normalized to KCNQ2WT (100 ± 24.1%, n = 5) and KCNQ2 + KCNQ3 (100 ± 4.4%, n = 6), respectively, were 8.5 ± 25.4%
(n = 5) for KCNQ2F304S and 20.2 ± 11.2% (n = 7) for KCNQ2F304S + KCNQ3WT. (D) G-V relations of KCNQ2 + KCNQ3 (black open square) and KCNQ2F304S + KCNQ3WT (gray open
inverted triangle). V1/2 for KCNQ2WT + KCNQ3WT: −41.8 ± 1.2 mV (n = 6) and for KCNQ2F304S + KCNQ3WT: −10.8 ± 1.5 mV (n = 7). Currents from KCNQ2F304S alone were too
small to obtain reliable G-V relations. (E to G) Representative current traces for KCNQ2Y237C alone, or coexpressed with KCNQ3WT, or KCNQ3A315T. Insets: Western blots for
membrane expression of the mutants. For KCNQ2Y237C + KCNQ3WT and KCNQ2Y237C + KCNQ3A315T, the KCNQ3 protein was probed. (H) Steady-state current amplitudes
were 17.8 ± 1.4 A (n = 4) for KCNQ3A315T and 0.3 ± 0.1 A (n = 10) for KCNQ2Y237C + KCNQ3A315T. (I and J) Representative current traces for KCNQ3Y266C alone or
coexpressed with KCNQ2WT. Inset: Western blot results for membrane expression of the mutant. (K) Steady-state currents normalized to KCNQ2 + KCNQ3 (100 ± 21.2%,
n = 6) were 67.6 ± 27.8% (n = 5) for KCNQ2WT + KCNQ3Y266C. (L) G-V relations of KCNQ2 + KCNQ3 (black open square) and KCNQ2WT + KCNQ3Y266C mutant (gray open inverted
triangle). V1/2 for KCNQ2WT + KCNQ3WT: −41.0 ± 0.9 mV (n = 6) and for KCNQ2WT + KCNQ3Y266C: −26.9 ± 1.3 mV (n = 5). Statistical significance was determined by Student’s
t test. *P < 0.05; ***P < 0.001.
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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Retigabine rescues the currents of KCNQ3 mutant by
restoring the E-M coupling
RTG is the first voltage-gated K+ channel activator approved for
clinical use as an antiepileptic drug (44), and it specifically activates
KCNQ2 to KCNQ5 channels by shifting the voltage dependence
of channel opening to more negative potentials (56, 57). Previous
studies have suggested that RTG binds to the pore domain of the
channels through interactions with several residues and demonstrated that a conserved tryptophan residue in the S5 helix (W236 in
KCNQ2; W265 in KCNQ3) is essential for RTG effects (40, 58–60).
Consistent with functional studies, a recent cryo-EM structure of
human KCNQ2 in complex with RTG (37) revealed that RTG binds
at the intersubunit interface of the channel pore domain, by mainly
forming hydrogen bonds with the side chain of W236, S303, and the
main-chain carbonyls of L299 and F305, as well as hydrophobic
interactions with residues W236, F240, L243, L272, L299, F304, and
F305. We found that several RTG-interacting residues overlap
(or are in close proximity) with residues important for the AO state
E-M coupling (such as S303 and F304) (Fig. 6A and fig. S5A), suggesting that RTG may directly modulate E-M coupling in KCNQ2
and KCNQ3. We therefore examined the effects of RTG on the E-M
coupling in KCNQ3 using the AO-less mutant KCNQ3A315T/S342F
(equivalent to KCNQ2S303F). Application of a saturating concentration (100 M) of RTG led to a partial rescue of KCNQ3A315T/S342F
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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currents (Fig. 6B). For KCNQ3A315T channels, 100 M RTG produced
a large hyperpolarizing shift (~−52 mV) in the G-V relation; how
ever, the voltage dependence of activation of the RTG-rescued
KCNQ3A315T/S342F channels was notably right-shifted compared to
KCNQ3 A315T (Fig. 6C), suggesting that RTG partially restored
channel function in the mutant. We also carried out VCF experiments in the presence and absence of RTG using a voltage protocol
that highlights kinetics of VSD deactivation, which are prominently
affected by RTG (Fig. 6D). Consistent with a previous report (45),
KCNQ3* G-V and F-V relations closely overlapped and exhibited
similar RTG-mediated shifts to negative potentials (~−47 mV),
suggesting that RTG binding within the pore domain can be readily
transduced to the VSD via the tight coupling between pore opening
and VSD activation (Fig. 6E). The AO-less KCNQ3*S342F mutant
exhibited no currents under control condition but retained robust
fluorescence signals (Figs. 2I and 6D). In the presence of 100 M
RTG, the F-V relation of KCNQ3*S342F was slightly shifted by ~−15 mV
(Fig. 6E), consistent with partial restoration of the coupling between pore opening and VSD activation. The difference in the
coupling between pore opening and VSD activation was also revealed
by VSD kinetics. Similar to previous studies (45), RTG affected the
KCNQ3* VSD kinetics by slowing the VSD deactivation rate (Fig. 6,
D and F), which is consistent with RTG binding to the pore domain
and altering the E-M coupling. Compared to KCNQ3*, KCNQ3*S342F
showed a much faster VSD deactivation kinetics (Fig. 6, D and F).
This effect is comparable to previously reported proximal C terminus mutations in KCNQ3 that uncoupled the pore and the VSD (45)
and may reflect the differences in VSD function when the influence of the pore was weakened by the S342F mutation. RTG also
slowed the VSD deactivation rate of KCNQ3*S342F but to a much lesser
extent compared to KCNQ3* (Fig. 6, D and F), suggesting that RTG
may restore some of the E-M coupling. Together, these results suggest that RTG interacts with critical residues to directly modulate the
E-M coupling in KCNQ2 and KCNQ3. When the E-M coupling is
intact (KCNQ3A315T), transduction of RTG binding from the pore
to the VSD is robust and efficient. On the other hand, when the
E-M coupling is abolished (KCNQ3A315T/S342F), RTG can restore
the E-M coupling to partially rescue channel function, but fails to
have the same influence on the voltage dependence of VSD activation and VSD deactivation kinetics.
Retigabine rescues some epilepsy-associated KCNQ2
and KCNQ3 mutants by modulating the E-M coupling
We then further explored if RTG can rescue disease-linked KCNQ2
and KCNQ3 mutants with compromised E-M coupling (Fig. 5).
These epilepsy-associated mutations are located near or within the
binding pocket of RTG (Fig. 6A), suggesting that RTG may modulate the E-M coupling of these mutants. For the KCNQ3A315T/Y266C
mutant (55) that behaves similarly to our designed KCNQ3 AO-less
mutants (Fig. 2, G and H) and abolished the currents when expressed alone (Figs. 5I and 7A), 100 M RTG was able to rescue
a small but significant K+ current relative to control condition
(Fig. 7, A and B), reflecting a partial restoration of the E-M coupling
by RTG. When the KCNQ3Y266C mutant is coexpressed with wildtype KCNQ2, 100 M RTG shifted the voltage dependence of
channel opening (by ~−17 mV) to a level similar to wild-type
KCNQ2 + KCNQ3 channels and increased the maximum conductance (by >40%) (Fig. 7, C and D). We found that 100 M RTG also
enhanced the currents of the EIEE-linked KCNQ2F304S mutant
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wild-type KCNQ3 resulted in near-complete suppression of currents
despite robust expression of the channel protein detected in the
membrane (Fig. 5, E and F, and fig. S3C). Coexpression of the
mutant with KCNQ3A315T also strongly suppressed the currents of
KCNQ3A315T channels (Fig. 5, G and H, and fig. S3C), producing a
more severe loss-of-function phenotype than our designed AO-less
mutants (Fig. 4, G, H, and K). With the homologous mutation on
KCNQ3A315T, KCNQ3A315T/Y266C alone abolished the currents without
preventing the expression of the channel protein to the membrane
(Fig. 5I and fig. S3C), suggesting that it functions as an AO-less
mutant (similar to Fig. 2, G and H). Coexpression of the KCNQ3Y266C
mutant with wild-type KCNQ2 did not significantly affect the M-current
amplitude (Fig. 5, J and K) but shifted the G-V relation to more positive
voltages (shifted ~+14 mV) compared to the wild-type KCNQ2 +
KCNQ3 (Fig. 5L), mirroring the effects of our designed AO-less
mutants (Fig. 4, E, F, I, and J). Mutants KCNQ2I238V and KCNQ2I238L,
however, were found to have mild effects on the current amplitude
(fig. S5, C to E and G to I) and the G-V relation when expressed alone
(shifted ~+12 and ~+5 mV, respectively) or coexpressed with wildtype KCNQ3 (shifted ~+4 and ~+7 mV, respectively) (fig. S5, F and
J). To mimic heterozygosity of disease-linked mutations, we coexpressed the KCNQ2 mutants with wild-type KCNQ2 and KCNQ3
subunits in a 0.5:0.5:1 ratio. In this configuration, KCNQ2F304S mod
erately suppressed M-current amplitude (fig. S4, E, F, and I) and
shifted the G-V relation (~+12 mV) compared to the wild-type control (fig. S4J), whereas KCNQ2Y237C exerted a dominant-negative effect that strongly suppressed M-current amplitude (fig. S4, E,
G, and I). Coexpression of KCNQ3Y266C mutant with wild-type KCNQ3
and KCNQ2 in a 0.5:0.5:1 ratio produced a small shift (~+6 mV)
in G-V relation (fig. S4J) and did not significantly affect the M-current
amplitude (fig. S4, E, H, and I). These results together demonstrate the
physiological importance of the AO state and suggest that disrupt
ing the AO state E-M coupling in KCNQ2 and KCNQ3 is a mechanism contributing to some neonatal epilepsies.
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(53, 54) + wild-type KCNQ3 channels (Fig. 7E) by shifting the G-V
relation to more negative potentials (~−43 mV) and increasing the
maximum conductance (by >25%) (Fig. 7F). To estimate the outcome in heterozygous conditions, we performed RTG experiments
in channel configurations that mimic the genetic balance of the
disease-linked mutants. When KCNQ2F304S is coexpressed with
wild-type KCNQ2 and KCNQ3 subunits in a 0.5:0.5:1 ratio, RTG
enhanced the currents by shifting the G-V relation to more negative
potentials (~−43 mV) (fig. S6A) and increasing the maximum
conductance (~2-fold) (fig. S6B). Similarly, when KCNQ3Y266C is
coexpressed with wild-type KCNQ3 and KCNQ2 subunits in a
0.5:0.5:1 ratio, RTG potentiated the currents by shifting the voltage
dependence of opening (by ~−41 mV) (fig. S6A) and increasing the
maximum conductance (~2.5-fold) (fig. S6B). Despite the profound effects of RTG on some of the disease-linked mutants and
KCNQ3A315T/S342F (Fig. 6), RTG did not rescue the currents of
KCNQ2W218R, KCNQ2Y237C, KCNQ2S303F, or KCNQ3A315T/W247R
mutant (fig. S6C). Together, these results demonstrate that RTG
can rescue KCNQ2 and KCNQ3 mutants with disrupted E-M coupling
and suggest that other small-molecule KCNQ openers with similar
mechanisms to modulate E-M coupling can benefit the treatment of
some neonatal epilepsies.
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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DISCUSSION

Elucidating the molecular mechanism for E-M coupling is an important step toward understanding the voltage-dependent gating of
Kv channels. Recent structure-function studies revealed that the
KCNQ1 channel features a two-stage hand-and-elbow E-M coupling
mechanism (15), where two steps of VSD activation, from the resting to intermediate and lastly to the fully activated state (9–15), trigger two sets of E-M coupling interactions that generate two distinct
conductive IO and AO states (fig. S7A) (12–18). This E-M coupling
mechanism and the regulation of the IO and AO states define the
gating, pharmacology, physiology, and pathophysiology of KCNQ1
(fig. S7) (12–18). KCNQ2 to KCNQ5 are homologous to KCNQ1 in
structure (7, 8, 37, 39, 41) and share important characteristics of
gating mechanism with KCNQ1, such as dependence on phosphatidylinositol 4,5-bisphosphate (PIP2) (23, 61, 62) and calmodulin
(63–65). However, whether the KCNQ2-KCNQ5 channels share
the same E-M coupling mechanism in their voltage-dependent
gating with KCNQ1 remains unclear. In this study, we provided functional evidence that the neuronal homolog KCNQ2 and KCNQ3
channels are different from KCNQ1 in which they feature a single
AO state but with a conserved E-M coupling mechanism specific
for the AO state (Figs. 1 to 3 and fig. S7A). We showed that the AO
9 of 14
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Fig. 6. Retigabine restores E-M coupling to rescue the currents of AO-less KCNQ3 mutant. (A) Mapping the key AO state E-M coupling residue S303 (blue) and the
EIEE-associated residues Y237, I238, and F304 (magenta) onto the retigabine-bound human KCNQ2 cryo-EM structure (PDB: 7CR7). Brackets indicate amino acid numbers
for KCNQ3. S5 and S6 from a neighboring subunit are shown in gold. (B) Representative current traces and (C) G-V relations of KCNQ3A315T/S342F before and after 100 M
retigabine. V1/2 for KCNQ3A315T/S342F with 100 M retigabine (blue filled circle): −6.2 ± 1.0 mV (n = 9). Dashed lines are fits for KCNQ3A315T with V1/2 for control (black): −47.3
± 0.8 mV (n = 5) and 100 M retigabine (blue): −99.2 ± 1.9 mV (n = 5). (D) Representative fluorescence deactivation traces of KCNQ3* and KCNQ3*S342F before (green) and
after (cyan) 100 M retigabine. (E) F-V relations of KCNQ3* and KCNQ3*S342F before and after 100 M retigabine. V1/2 for KCNQ3* control (green open circle): −52.7 ± 4.6 mV
(n = 4), for KCNQ3* with 100 M retigabine (cyan open circle): −99.8 ± 5.9 mV (n = 3), for KCNQ3*S342F control (green filled circle): −11.5 ± 0.2 mV (n = 6), and for
KCNQ3*S342F with 100 M retigabine (cyan filled circle): −26.4 ± 1.4 mV (n = 8). (F) Fluorescence deactivation time constants of KCNQ3* and KCNQ3*S342F before and after
100 M retigabine. Dotted lines are semi-log line fits. VCF was recorded using the deactivation voltage protocol illustrated at the top of (D).
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state E-M coupling of M-channels is physiologically important and
is a target of epilepsy-associated mutations (Figs. 4 and 5 and fig.
S7A). Last, we took advantage of a well-studied neuronal KCNQ
channel opener RTG to demonstrate that modulating the AO state
E-M coupling holds therapeutic potential against congenital epilepsy (Figs. 6 and 7). This work is built on the foundation of a well-
established mechanistic framework for KCNQ1 gating (12–18) and
strengthens our understanding of the role of E-M coupling in physiology, pathophysiology, and pharmacology of KCNQ channels.
Recent cryo-EM structures revealed that the neuronal KCNQ
channels share similar VSD conformations with KCNQ1, representing the conserved fully activated VSD state (Fig. 1A) (7, 8, 37, 41).
Consistent with other studies (45, 47, 48), our VCF results showed
that KCNQ3, unlike KCNQ1, exhibits a one-step VSD transition
based on steady-state voltage-dependent activation (Fig. 1, D and E).
We then demonstrated with VSD-arresting charge-switching mutations that KCNQ2 and KCNQ3 only conduct in the AO state when
the VSDs occupy the fully activated conformation (Fig. 1, F to K),
contrasting the two open states of KCNQ1 (12–18). Mutations that
Yang et al., Sci. Adv. 8, eabo3625 (2022)
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target the AO state E-M coupling completely abolished the currents
(Fig. 2), further supporting the idea that KCNQ2 and KCNQ3 only
feature an AO state. This conserved single AO state defines the
properties of KCNQ2 and KCNQ3 channels, including the mechanism
of E-M coupling, sensitivity to permeant ions, and pharmacology
(Figs. 2 and 3), which are similar to the AO state of the KCNQ1
channel (fig. S7) (12, 15–17, 19).
Although KCNQ2 and KCNQ3 predominantly activate with a
fully activated VSD conformation, some differences with AO state
properties of KCNQ1 should be noted. First, the AO-only KCNQ2
and KCNQ3 channels have a negative V1/2 (~−40 mV) of G-V
relations and fast activation kinetics that resemble KCNQ1, which is
IO-predominant. In contrast, the KCNQ1 AO state exhibits a right-
shifted G-V relation (V1/2 ~ +40 mV) and slower activation kinetics
(12–18, 64) compared to KCNQ2 and KCNQ3 (Fig. 1, D and E)
(45, 47, 48). While these differences in the AO state activation properties may have important implications for the primary physiological
roles of KCNQ2/3 (regulation of neuronal excitability) (25, 26) versus
KCNQ1 (cardiac action potential repolarization) (1, 2), it remains
10 of 14

Downloaded from https://www.science.org at Washington University on August 30, 2022

Fig. 7. Retigabine modulates the E-M coupling to rescue epilepsy-linked mutants of KCNQ2 and KCNQ3. (A) Representative current traces of KCNQ3A315T/Y266C
before (black) and after (blue) 100 M retigabine. Single traces at +40 mV (left) and all traces after retigabine (right) are shown. (B) Steady-state current amplitudes of
KCNQ3A315T/Y266C were 0.05 ± 0.01 A (n = 4) for control (black) and 0.16 ± 0.04 A (n = 4) for 100 M retigabine (blue). Statistical significance was determined by paired
Student’s t test. *P < 0.05. (C) Representative current traces of KCNQ2WT + KCNQ3Y266C before (black) and after (blue) 100 M retigabine. Single traces at +40 mV (left) and
all traces after retigabine (right) are shown. (D) G-V relations of KCNQ2WT + KCNQ3Y266C before and after 100 M retigabine. V1/2 for control (black): −29.2 ± 2.9 mV (n = 4)
and for 100 M retigabine (blue): −46.4 ± 9.4 mV (n = 4). (E) Representative current traces of KCNQ2F304S + KCNQ3WT before (black) and after (blue) 100 M retigabine.
Single traces at +40 mV (left) and all traces after retigabine (right) are shown. (F) G-V relations of KCNQ2F304S + KCNQ3WT before and after 100 M retigabine. V1/2 for control
(black): −22.2 ± 2.6 mV (n = 5) and for 100 M retigabine (blue): −65.5 ± 6.0 mV (n = 5).
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(Fig. 4). Disrupting the E-M coupling in KCNQ2 versus KCNQ3
has differential consequences to the M-channel function (Fig. 4).
This result may have some implications for why we observe far
more disease-associated mutations in KCNQ2 compared to KCNQ3
and for the severity of disease manifestations. For instance, most
BFNC mutations are found in KCNQ2 with less mutations identified in KCNQ3, whereas the EIEE mutations that cause a more
severe form of childhood epilepsy are far more predominant in
KCNQ2 (31, 75). It should be noted that differential expression of
KCNQ2 and KCNQ3 during development (expression of KCNQ2
preceding that of KCNQ3) (76) may also underlie the higher pathogenic impact of KCNQ2 versus KCNQ3 variants. The AO state and
its E-M coupling mechanism not only defines the fundamental
properties of the M-channel (Figs. 3 and 4) but also is a target in
disease pathology as several epilepsy-associated mutations were
found to disrupt the E-M coupling (Fig. 5 and figs. S4 and S7A).
Last, we demonstrated with a small-molecule drug RTG that the
E-M coupling could be specifically modulated to rescue the currents
of a KCNQ3 AO-less mutant (Fig. 6 and fig. S7B) and the function
of diseased M-channels (Fig. 7 and fig. S6), suggesting that targeting
the conserved AO state E-M coupling is a potential antiepileptic
strategy.
MATERIALS AND METHODS

Constructs and mutagenesis
Site-directed mutations were introduced into KCNQ2 and KCNQ3
channels using overlap extension and high-fidelity polymerase chain
reaction (PCR). The presence of all desired mutations was verified by
DNA sequencing. The complementary RNA (cRNA) of the channels
was synthesized by in vitro transcription using the mMessage
mMachine T7 or SP6 polymerase kit (Applied Biosystems–Thermo
Fisher Scientific). In experiments involving homomeric expression of
KCNQ3 channels, the A315T mutation was introduced to enable efficient trafficking and functional expression of KCNQ3 channels (46).
Xenopus oocyte channel expression
Stage V-VI oocytes were obtained from Xenopus laevis by laparotomy
procedure in accordance with the protocols approved by the Washington
University Animal Studies Committee (protocol #20190030) and by the
University of Alberta Animal Care Committee (protocol #AUP00001752).
Oocytes were digested with collagenase (0.5 mg/ml; Sigma-Aldrich,
St. Louis, MO) to remove the follicle cell layer. A total of 9.2 ng of
channel cRNA was then injected into each oocyte using Nanoject
(Drummond, Broomall, PA). For experiments involving coexpression
of KCNQ2 and KCNQ3, cRNAs were coinjected at 1:1 (KCNQ2:KCNQ3)
mass ratio, unless otherwise specified. For VCF experiments, all
injected cRNA amounts were doubled to attain higher surface
expression level. The injected oocytes were incubated at 18°C for at
least 2 days in ND96 solution [96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2,
1 mM MgCl2, 5 mM Hepes, 2.5 mM Na pyruvate, and 1% penicillin-
streptomycin (pH 7.6)] before recording.
Two-electrode voltage clamp and VCF
Microelectrodes were pulled from thin wall borosilicate glass (item
#B150-117-10, Sutter Instrument, Novato, CA) by a micropipette
puller (P-97 or P-1000, Sutter Instrument, Novato, CA) to a resistance
of 0.5 to 3 megohms when filled with 3 M KCl solution. Whole-cell
ionic currents were recorded from oocytes bathed in ND96 solution
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unclear why the gating features of KCNQ2 and KCNQ3 resemble
the KCNQ1 IO state, instead of the AO state. It will be interesting
for future studies to elucidate whether and how the differences in
AO voltage dependence and kinetics between KCNQ2/3 and KCNQ1
derive from the VSDs of these channels.
While the steady-state F-V relation only indicated one-step VSD
movement for KCNQ2 and KCNQ3 (Fig. 1E) (45, 47, 48), it should
be noted that the possibility of a transient “intermediate state” existing during VSD activation cannot be totally ruled out. It is possible
that such a VSD state may be kinetically observable based on
biexponential kinetics of VSD activation (Fig. 1D and fig. S7A), but
not stable enough to be detected in the steady state F-V (Fig. 1E),
nor sufficient to generate channel opening (fig. S7A). Two-step VSD
activation is a common feature in Kv channels. Besides KCNQ1, a
similar example is the Drosophila Shaker channel that exhibited two
steps in the kinetics and steady state of VSD activation (66, 67).
Some mutations in the Shaker channel were found to separate
the two VSD activation steps even more (68–70). However, unlike
KCNQ1, the Shaker channel only has one open state and no pore
opening at the intermediate VSD state (71). Here, we showed that
KCNQ2 and KCNQ3 are homologous to KCNQ1 but only feature
one open state as well (Figs. 1 to 3). These comparisons suggest that
one open state at the fully activated VSD conformation is the canonical mechanism in Kv channels, whereas the two open states
in KCNQ1 are an exception. The reason for the two KCNQ1 open
states is not clear and remains an important subject for future studies.
The E-M coupling interactions specific for the AO state are conserved in KCNQ2 and KCNQ3, suggesting that the mechanism
likely applies to many other domain-swapped Kv channels.
Besides the protein-protein interactions investigated in this study,
PIP2-mediated interactions are also important for E-M coupling. In
KCNQ channels, depletion of PIP2 closes channels (23, 45, 62). We
have previously shown in KCNQ1 that this is due to the disruption
of PIP2-mediated VSD-pore coupling (23). On the other hand, in
the presence of PIP2, mutations that target the protein-protein E-M
coupling also render nonfunctional channels (15). These results
suggest that both classes of interactions are important for E-M
coupling. Previous functional studies in KCNQ1 and KCNQ3
(23, 45, 61) as well as recent PIP2-bound KCNQ1 and KCNQ4
structures (8, 41) have revealed a conserved PIP2 binding pocket
responsible for PIP2-mediated VSD-pore coupling in KCNQ channels (fig. S8A). Mapping the PIP2 binding sites and the sites important
for protein-protein E-M coupling onto the human KCNQ2 structure revealed that they are spatially distinct (fig. S8B). However, the
close proximity between the two sites (fig. S8B) suggests that the
two E-M coupling mechanisms may interact allosterically to affect
each other. Therefore, the possibility of allosteric effects of AO-
disrupted mutations on PIP2 binding cannot be totally ruled out
(72). In addition, since RTG also regulates E-M coupling, it is
conceivable that PIP2 may modulate RTG effects (45, 73).
The AO-only feature and its specific E-M coupling mechanism
define not only the properties of homomeric KCNQ2 and KCNQ3
channels but also KCNQ2 in complex with KCNQ3, which is the
major form of the M-channels in neurons (4). The sensitivity to
permeant ions and pharmacology of the M-channels are similar to
those of KCNQ2 and KCNQ3 (Fig. 3) (19, 74). The E-M coupling
specific for the AO state is also physiologically important, as
demonstrated by the coexpression of KCNQ2 or KCNQ3 subunits
carrying the AO-less mutations with their wild-type counterparts
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(∆F/F) at the end of the test pulses to various voltages and normalizing
to the maximum fluorescence change. The F-V relation was then fitted
with a single-component Boltzmann equation (the same as G-V) or
a two-component Boltzmann equation in the form of F/Fmax = A1/
(1 + exp(−(V − V1/2,1)/k1)) + A2/(1 + exp(−(V − V1/2,2)/k2)), where
A1 + A2 = 1. The fluorescence deactivation time course was fitted
with a single-exponential decay function to extract the time constant. Experiments were conducted on at least two separate batches
of oocytes to confirm reproducibility. Statistical significance was
determined by Student’s t test for pairwise comparisons and by
one-way analysis of variance (ANOVA) followed by Tukey’s post
hoc test for multiple comparisons. All average data are presented as
mean ± SEM.

Electrophysiology data analysis
Electrophysiology data were analyzed with MATLAB (MathWorks,
MA) and Prism (GraphPad, CA) software. Steady-state current
amplitudes at the end of the +40-mV test pulse were used to compare the current amplitudes between wild-type and mutant channels.
The G-V relationship (with and without drug application) was
calculated by measuring the instantaneous tail currents following
test pulses to various voltages and normalizing to the maximum tail
current in control bath solution for each oocyte. The G-V relation
was then fitted with a single Boltzmann equation in the form of
G = Gmax/(1 + exp(−(V − V1/2)/k)), where Gmax is the maximum
conductance and is set equal to 1 in control condition, V is the test
pulse voltage, V1/2 is the voltage where channels are at half-maximal
activation, and k is the slope factor reflecting the steepness of the
curve. k = RT/zF, where R is the universal gas constant, T is the
absolute temperature, z is the equivalent valence, and F is the Faraday
constant. The change in Gmax after drug application was calculated
as (Gmax,drug − Gmax,ctrl)/Gmax,ctrl, where Gmax,ctrl = 1. To correct for
photobleaching, fluorescence signals were first baseline-subtracted
by linear fitting and extrapolating the signals at the holding potential
preceding each test pulses. The F-V relationship was derived after
baseline subtraction by obtaining the relative fluorescence change
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Western blot
Membrane and cytoplasmic proteins of oocytes were extracted
using the Mem-PER Plus Membrane Protein Extraction Kit (Thermo
Fisher Scientific). Equal amounts of protein samples were prepared
by adding 2× Laemmli sample buffer (Bio-Rad) and loaded on
SDS–polyacrylamide gel electrophoresis gels. After gel electrophoresis, membrane and cytoplasmic proteins were probed by
Western blot following standard protocols. KCNQ2 and KCNQ3
proteins were detected with primary antibodies rabbit anti-KCNQ2
(1:1000 dilution; Abcam, ab22897) and rabbit anti-KCNQ3 (1:1000
dilution; Abcam, ab66640), respectively, followed by goat anti-rabbit
secondary antibody (1:5000 dilution; Invitrogen, A16110), and
visualized using enhanced chemiluminescence (ECL Western
Blotting reagent, Thermo Fisher Scientific) and CL-XPosure Film
(Thermo Fisher Scientific). -Actin antibody (1:1000 dilution;
Abcam, ab8227) was used to probe for control proteins.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abo3625
View/request a protocol for this paper from Bio-protocol.
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using a CA-1B amplifier (Dagan, Minneapolis, MN) in two-electrode
voltage clamp (TEVC) mode. Signals were sampled at 1 kHz and
low-pass–filtered at 2 kHz using the Patchmaster software (HEKA,
Holliston, MA). Unless otherwise specified, currents were recorded
at holding potential of −80 mV, followed by 4-s depolarizing pulses
stepping from −120 to +60 mV in 10-mV increments, before
returning to −40 mV for 2 s to measure tail currents. For ion
permeation experiments, 100 mM K+ [100 mM KCl, 1.8 mM CaCl2,
1 mM MgCl2, and 5 mM Hepes (pH 7.6)] or 100 mM Rb+ [96 mM
RbCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM Hepes
(pH 7.6)] solutions were perfused onto oocytes to steady state. For
experiments comparing the current amplitudes, cRNAs encoding
wild-type and mutant channels were injected on the same day. The
injected oocytes were later recorded on the same day to control for
channel expression and allow for current amplitude comparison
between wild-type and mutant channels. For VCF (45), oocytes
expressing channels were labeled for 20 min on ice with 200 M
Alexa Fluor 488 C5-maleimide (Thermo Fisher Scientific, Waltham,
MA) in high K+ depolarizing solution [100 mM KCl, 1.8 mM CaCl2,
1 mM MgCl2, and 5 mM Hepes (pH 7.6)]. The oocytes were then
washed three times with ND96 solution after labeling and kept on
ice until recording. Whole-cell currents were recorded in ND96
solution using similar instruments as the TEVC setup. The fluorescence emission was simultaneously collected by a PIN040-A
photodiode (OSI Optoelectronics, Hawthorne, CA) using an Olympus
IX51 inverted microscope connected to a patch-clamp head unit/
amplifier in voltage clamp mode (Axopatch-1C, Axon Instruments).
A PhlatLight LED (Luminus Devices) was used as the light source.
The amplified signals were low-pass–filtered at 200 Hz and sampled
at 1 kHz using Patchmaster (HEKA, Holliston, MA). All recordings
were performed at room temperature (20° to 23°C). C28 (alizarin
blue black bg, MP Biomedicals, OH) and RTG (Toronto Research
Chemicals) were stored as 100 mM stocks in dimethyl sulfoxide and
diluted in bath solutions to working concentrations each experimental day. All other chemicals were obtained from Sigma-Aldrich
(St. Louis, MO).
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